Martin Andrews
Direktor/Vorstandsmitglied bei Freeline Therapeutics Ltd.
Aktive Positionen von Martin Andrews
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | Direktor/Vorstandsmitglied | 27.05.2020 | - |
Karriereverlauf von Martin Andrews
Ehemalige bekannte Positionen von Martin Andrews
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
FREELINE THERAPEUTICS HOLDINGS PLC | Direktor/Vorstandsmitglied | 01.10.2018 | 20.02.2024 |
Independent Dir/Board Member | 06.08.2020 | 20.02.2024 | |
GSK PLC | Corporate Officer/Principal | 01.06.2008 | 01.07.2018 |
New Context Ltd. | Direktor/Vorstandsmitglied | - | - |
ORCHARD THERAPEUTICS PLC | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Martin Andrews
University of Salford | Undergraduate Degree |
Statistik
International
Vereinigtes Königreich | 8 |
Operativ
Director/Board Member | 5 |
Corporate Officer/Principal | 1 |
Independent Dir/Board Member | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GSK PLC | Health Technology |
Private Unternehmen | 5 |
---|---|
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Health Technology |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Freeline Therapeutics Holdings Plc
Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Orchard Therapeutics Plc
Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
New Context Ltd. |
- Börse
- Insiders
- Martin Andrews
- Erfahrung